Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial

INTRODUCTION: Magnetic resonance imaging (MRI) is increasingly used in patients with rheumatoid arthritis (RA) to determine residual inflammation after treatment and as a predictor of structural damage progression. Establishing an optimal threshold of inflammatory activity that predicts lower risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Harris A., Baker, Joshua F., Østergaard, Mikkel, Ye, June, Emery, Paul, Conaghan, Philip G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822846/
https://www.ncbi.nlm.nih.gov/pubmed/31278695
http://dx.doi.org/10.1007/s12325-019-01020-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822846/
https://www.ncbi.nlm.nih.gov/pubmed/31278695
http://dx.doi.org/10.1007/s12325-019-01020-6

Ejemplares similares